The FDA says a J&J unit received 227 complaints about various products and most often closed them without a thorough investigation.
U.S. regulators would inspect more drug manufacturing facilities in China, India and other foreign countries in order to ensure quality.
Medical device maker Boston Scientific Corp. said it received U.S. approval for a new type of stent to treat blocked arteries in the legs.
Agilent Technologies Inc. said it is buying the cancer diagnostic company to help it develop a wider range of cancer-fighting products.
Medical device maker Medtronic Inc. said Wednesday that federal prosecutors have closed their investigation of the company's InFuse bone graft.
Medical device maker has agreed to buy Hemosphere Inc., which makes a vascular graft that is used in kidney dialysis patients, for $17 million in cash.
Shares of the medical diagnostics company slipped after it announced that the government was concerned over its marketing and quality-control testing.
There is nothing worse than throwing a bunch of consultants at a problem without knowing the boundaries of the project or defining the expected results. Unfortunately, it happens all the time. It ends in frustration for all parties involved. A formal scope of work (SOW) helps both the client and the consultant to set expectations of each other, and agree on basic assumptions that are critical to success.
The company said there were no allegations that drugs were illegally diverted to someone without prescriptions and no patients were harmed.
The two men performed pioneering research on how cells express their genetic information at The Rockefeller University in New York City.
Naari AG asked Nebraska officials to quarantine its supply of sodium thiopental because it was "illegally diverted" from its supply chain.
South Korean officials say they seized smuggled capsules containing powdered remains of dead babies, which some believe can cure a variety of diseases.
Attorneys general from across the country alleged that Abbott marketed its anti-seizure drug Depakote for unapproved uses.
Pharmaceutical companies face increased competition to meet consumer demand, which means tighter and more complex deals with contract manufacturers.
Pfizer, AstraZeneca and Eli Lilly & Co. are dusting off two dozen old drugs that failed to treat one disease but might treat another.
The FDA recently issued a Form 483, which said inspectors found problems in Impax's quality control laboratory.
The Johnson & Johnson antibiotic is able to cure a vast majority of the rare bacterial infections, which could be use as a potential bioterrorism agent.
Medical device maker Hologic Inc. said Monday that it will buy diagnostic test maker Gen-Probe for about $3.72 billion in an all-cash deal.
The company will look to fill positions at its new type 1 diabetes research center in Seattle and at a manufacturing plant in North Carolina.
New CEO Alex Gorsky said one of his short-term priorities is to get "reliable" consumer products back on store shelves.
The bill is the latest in recent years to try to slow down meth production, which uses cold and allergy medicine containing ephedrine or pseudoephedrine.
Antibiotics have saved countless lives in treating a variety of diseases, but some argue their use in meat breeds antibiotic-resistant germs.
Baxter International Inc. will employ about 1,500 people to make plasma-based therapies that treat chronic and life-threatening illnesses.
The European Union's competition regulator says it has approved Johnson & Johnson's $21.3 billion acquisition of Swiss orthopedics maker Synthes.
The justices questioned whether the federal law governing overtime pay should apply to those who try to persuade doctors to prescribe certain drugs.